PerpEquities

AbbVie Inc. (ABBV) balance sheet

NYSE · Healthcare · Drug Manufacturers - General · 57,000 employees · CEO Robert A. Michael

Price
$294.89 +1.41%
Market cap
$521B
Enterprise value
$585B
Last report
Q3 '26 filed 2026-09-30
Next report
2027-02-03 EPS est. $3.90

At the end of Q2 '26 AbbVie Inc. (ABBV) held $6.57B in cash and short-term investments against $70.8B of debt incl. leases. Total assets $135B, total liabilities $141B, shareholders' equity -$5.94B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$13.3B$12.8B$18.1B$13.1B$7.26B$5.52B$5.18B$6.47B$5.63B$5.23B$9.39B$6.57B
Short-term investments$3M$2M$2M$27M$28M$31M$1M$0$42M$28M$0$0
Receivables$11.4B$11.2B$11.9B$11.7B$11.5B$10.9B$12.5B$12.6B$12.8B$12.6B$12.5B$13.8B
Inventory$3.98B$4.1B$4.25B$4.22B$4.45B$4.18B$4.53B$4.96B$4.94B$4.95B$5.05B$5.13B
Other current assets$4.54B$4.93B$4.61B$4.72B$4.58B$4.93B$5.5B$5.2B$5.16B$6.27B$6.61B$8.15B
Current assets$33.2B$33B$38.9B$33.8B$27.8B$25.6B$27.7B$29.3B$28.5B$29.1B$33.5B$33.7B
Property, plant & equipment (net)$4.93B$4.99B$4.98B$5.02B$5.14B$5.13B$5.24B$5.28B$5.48B$6.37B$5.69B$5.8B
Long-term investments$275M$304M$305M$272M$267M$279M$287M$310M$291M$299M$268M$266M
Goodwill$32.1B$32.3B$33.4B$33.4B$35.3B$35B$35.3B$35.6B$35.6B$35.6B$35.6B$35.5B
Intangible assets$58.6B$55.6B$62.2B$60.2B$66.6B$60.1B$58.5B$57B$54.3B$52.6B$50.9B$49.1B
Other non-current assets$7.09B$8.51B$9.07B$9.2B$8.29B$9.14B$9.19B$9.66B$9.64B$9.95B$10.5B$10.7B
Non-current assets$103B$102B$110B$108B$116B$110B$108B$108B$105B$105B$103B$101B
Total assets$136B$135B$149B$142B$143B$135B$136B$137B$134B$134B$136B$135B
Liabilities
Accounts payable$29.6B$3.69B$31.3B$29.3B$30.4B$31.9B$31B$31.8B$33.4B$34.4B$33.6B$33.2B
Accrued expenses$0$24.2B$0$0$0$0$0$0$0$0$0$0
Short-term debt$5.12B$7.19B$10.2B$12.6B$12.6B$6.8B$5.36B$7.52B$5.77B$8.56B$8.33B$8.34B
Other current liabilities$88M$0$68M$33M$94M$35M$82M$413M$257M$312M$164M$128M
Current liabilities$34.8B$37.8B$41.5B$41.9B$43.1B$38.7B$36.4B$39.8B$39.4B$43.3B$42.1B$41.6B
Long-term debt$55.6B$52.2B$63.8B$58B$58.5B$60.3B$64.5B$63B$63B$59.6B$64.5B$62.5B
Lease obligations (non-current)$0$762M$0$0$0$720M$0$0$0$711M$0$0
Deferred tax liabilities$2.04B$8.63B$2.72B$2.73B$2.75B$7.63B$2.58B$2.55B$2.48B$7.96B$2.33B$2.28B
Other non-current liabilities$31.6B$24.9B$32.8B$32.4B$33B$24.4B$31.2B$32B$31.7B$25.6B$34.1B$34.6B
Non-current liabilities$89.3B$86.5B$99.3B$93.2B$94.3B$93B$98.3B$97.6B$97.1B$93.9B$101B$99.4B
Total liabilities$124B$124B$141B$135B$137B$132B$135B$137B$136B$137B$143B$141B
Equity
Common stock & paid-in capital$18M$18M$18M$18M$18M$18M$18M$18M$18M$18M$18M$18M
Retained earnings$933M-$1B-$2.38B-$3.77B-$4.96B-$7.9B-$9.53B-$11.5B-$14.2B-$15.5B-$17.9B-$17.3B
Accumulated other comprehensive income-$2.35B-$2.31B-$2.45B-$2.51B-$2.33B-$1.93B-$1.74B-$1.54B-$1.57B-$1.14B-$1.15B-$1.16B
Shareholders' equity$12.1B$10.4B$8.01B$6.78B$6.03B$3.33B$1.42B-$183M-$2.64B-$3.27B-$6.66B-$5.94B
Debt
Total debt (incl. leases)$60.7B$60.1B$74B$70.6B$71.1B$67.8B$69.9B$70.5B$68.7B$68.9B$72.9B$70.8B
Net debt (debt - cash)$47.5B$47.3B$55.9B$57.5B$63.8B$62.3B$64.7B$64B$63.1B$63.6B$63.5B$64.3B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-01